Harrell James Archie Jr - Net Worth and Insider Trading

Harrell James Archie Jr Net Worth

The estimated net worth of Harrell James Archie Jr is at least $163 dollars as of 2024-11-13. Harrell James Archie Jr is the Chief Commercial Officer of Avalo Therapeutics Inc and owns about 13 shares of Avalo Therapeutics Inc (AVTX) stock worth over $163. Details can be seen in Harrell James Archie Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harrell James Archie Jr has not made any transactions after 2021-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Harrell James Archie Jr

To

Harrell James Archie Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harrell James Archie Jr owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .

Click here to see the complete history of Harrell James Archie Jr’s form 4 insider trades.

Insider Ownership Summary of Harrell James Archie Jr

Ticker Comapny Transaction Date Type of Owner
AVTX Avalo Therapeutics Inc 2021-12-10 Chief Commercial Officer

Harrell James Archie Jr Latest Holdings Summary

Harrell James Archie Jr currently owns a total of 1 stock. Harrell James Archie Jr owns 13 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2021, with a value of $163.

Latest Holdings of Harrell James Archie Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVTX Avalo Therapeutics Inc 2021-12-10 13 12.53 163

Holding Weightings of Harrell James Archie Jr


Harrell James Archie Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Harrell James Archie Jr has made a total of 5 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 0 shares on December 10, 2021, which cost Harrell James Archie Jr around $1,716.

Insider Trading History of Harrell James Archie Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harrell James Archie Jr Trading Performance

GuruFocus tracks the stock performance after each of Harrell James Archie Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harrell James Archie Jr is -9.95%. GuruFocus also compares Harrell James Archie Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harrell James Archie Jr within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Harrell James Archie Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Harrell James Archie Jr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Harrell James Archie Jr Ownership Network

Ownership Network List of Harrell James Archie Jr

No Data

Ownership Network Relation of Harrell James Archie Jr

Insider Network Chart

Harrell James Archie Jr Owned Company Details

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Harrell James Archie Jr is the Chief Commercial Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Harrell James Archie Jr made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 74,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 331 shares were bought by its insiders, resulting in a net sale of 15,017 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avalo Therapeutics Inc Insider Transactions

No Available Data

Harrell James Archie Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Harrell James Archie Jr. You might contact Harrell James Archie Jr via mailing address: C/o Cerecor Inc., 400 E. Pratt Street, Suite 606, Baltimore Md 21202.